Latest in Noaa Rfk
Sort by
218 items
-
RFK Jr’s vaccine views ‘dangerous’, cousin Caroline Kennedy warns Australian audience
Outgoing US ambassador to Australia discusses Trump’s pick for health secretary, and concedes climate action under president-elect may not be as ‘fast’. The outgoing US ambassador to Australia, ...World - The Guardian - November 18 -
Public health leader: RFK Jr. 'fails on all fronts' as potential agency leader
A leading public health organization is sounding the alarm over Robert F. Kennedy Jr., President-elect Trump’s pick to lead the Department of Health and Human Services. The American Public Health ...Politics - The Hill - November 18 -
2 health stocks are buys. They've been beaten up enough on Trump's RFK Jr. pick for HHS
The health care sector has been the big loser in the market since the election.Business - CNBC - November 18 -
Caroline Kennedy calls Trump HHS pick RFK Jr.'s vaccine views ‘dangerous’
RFK Jr. ran a longshot presidential bid and then endorsed Republican nominee Donald Trump. Many of his family members denounced both actions.Business - CNBC - November 18 -
Dental company stocks jump amid RFK Jr.'s health claims about fluoride
Robert F. Kennedy's Jr. push to remove fluoride from the nation's public water supply could benefit some companies. Here's why.Top stories - CBS News - November 18 -
Caroline Kennedy, a U.S. ambassador, says her cousin RFK Jr. holds 'dangerous' views on vaccines
Caroline Kennedy, the U.S. ambassador to Australia, bashed her cousin Robert F. Kennedy Jr. this week over his views on vaccinations, calling them “dangerous.”Politics - NBC News - November 18 -
Here Are the GOP Senators Best Positioned to Take on Trump
These are the Republican lawmakers who, by dint of age, independence or unusual constituencies, could provide a crucial check on Trump’s dictatorial ambitions.Politics - Politico - 6 days ago -
RFK Jr. is Trump's pick to lead HHS — here's what he could do with that power
Trump's selection is sounding the alarm in the public health community and leaving the biotech and pharmaceutical industries cautious of changes to come.Business - CNBC - November 19